“If you develop a product that doesn’t exist, it takes time to educate the market. It’s not an easy journey, but an exciting one. If you’re building a product that’s neither a laboratory test nor a rapid diagnostics test, but something that works as good as laboratory test and is as easy to use as a rapid test, it takes effort to explain that to people. Not everyone easily understands the concept of microfluidics or nanotechnology behind our products, so there’s a bit of education involved when introducing novel and innovative technologies such as ours. Of course, the vast bulk of people I meet are well educated, representing lab managers or Key Opinion Leaders, and the response is always favorable. But it’s not always like this when our distributors go out into the field. There, people that are used to working with rapid diagnostics tests and nothing else can be reluctant towards new technologies. Even though the price point is similar, and the quality is better, the novelty factor sometimes causes adoption issues. For more receptive people, it’s fascinating to hear about Immuno-Magnetic Assay, our patented technology. They see the potential and believe that it’s going to have a big positive impact on the dengue health sector.”
“Even without BluSense it’s unlikely I would have remained in Academia for long as I do not have enough patience nor probably the right personality for being a scientist. I’d probably still be involved in innovation and likely in health care, maybe from some other aspects that I can’t foresee right now. Surely, I would be doing what I like the most: finding out-of-the-box solutions for addressing problems, asking provocative questions, convincing people to join a cause or project, and finding new perspectives to identify alternative scenarios. Independently on the sector, those are useful activities for advancing innovation”.
BluSense Diagnostics ApS
Follow his work at:
Facebook – BluSense Diagnostics
LinkedIn – @BluSenseDiagnostics
Twitter – @BluSenseDx
First published to Facebook on 6 July 2020